Sign In  |  Register  |  About Santa Clara  |  Contact Us

Santa Clara, CA
September 01, 2020 1:39pm
7-Day Forecast | Traffic

  • Search Hotels in Santa Clara

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Panbela Therapeutics Inc (NQ: PBLA )

N/A UNCHANGED
Last Price Updated: 4:00 PM EST, Mar 6, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Panbela Therapeutics Inc

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Panbela Announces Publication of Preclinical and Clinical Data Titled: Inhibition of Polyamine Biosynthesis Preserves β Cell Function in Type 1 Diabetes
From Panbela Therapeutics, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Panbela Announces Validation of European Patent in UK, Italy, Germany, France, and Spain for Claims of a Novel Process for the Production of SBP-101
Patent developed in collaboration with Syngene International Ltd. 
From Panbela Therapeutics, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Acceptance of Polyamine Inhibitor CAR-T Combination Abstract for Online Publication
From Panbela Therapeutics, Inc.
Via GlobeNewswire
Panbela to Host Third Quarter 2023 Earnings Conference Call on November 9, 2023
From Panbela Therapeutics, Inc.
Via GlobeNewswire
Panbela Announces Issuance of New Patent in China for Claims of a Novel Process for the Production of SBP-101
Patent developed in collaboration with Syngene International Ltd. 
From Panbela Therapeutics, Inc.
Via GlobeNewswire
Panbela to Present at the LD Micro Investor Conference
From Panbela Therapeutics, Inc.
Via GlobeNewswire
Why Smith & Wesson Brands Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket
Gainers Impel Pharmaceuticals Inc. (NASDAQ: IMPL) rose 41.3% to $0.54 in pre-market trading after falling 4% on Thursday. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Pre-market stock movers are a hot topic worth checking out on Friday with a look at the biggest winners and losers today! 
Via InvestorPlace
Panbela Announces Issuance of New Patent in Chile for Claims of a Novel Process for the Production of Flynpovi
Patent developed in collaboration with Sanofi 
From Panbela Therapeutics, Inc.
Via GlobeNewswire
Panbela to Present at H.C. Wainwright 25th Annual Global Investment Conference
From Panbela Therapeutics, Inc.
Via GlobeNewswire
Stocks That Hit 52-Week Lows On Wednesday
  Wednesday's session saw 150 companies set new 52-week lows. 
Via Benzinga
Panbela Announces Issuance of New Patent in Europe for Claims of a Novel Process for the Production of SBP-101
Patent developed in collaboration with Syngene International Ltd. 
From Panbela Therapeutics, Inc.
Via GlobeNewswire
Panbela to Host Second Quarter 2023 Earnings Conference Call on August 10, 2023
From Panbela Therapeutics, Inc.
Via GlobeNewswire
Panbela Opens Enrollment in UK and Germany for Aspire Trial in Pancreatic Cancer, All Countries/Regions in the Aspire Trial are Now Open and Actively Enrolling
Interim Data Analysis anticipated in Early 2024 
From Panbela Therapeutics, Inc.
Via GlobeNewswire
Earnings Scheduled For August 10, 2023
Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report quarterly loss at $0.39 per share on revenue of $1.60 million. 
Via Benzinga
Nasdaq Moves Lower; US Crude Oil Inventories Decline Less Than Projected
U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite moving lower on Wednesday. The Dow traded up 0.31% to 35,058.78 while the NASDAQ fell 0.21% to 14,323.99. The S&P 500, also... 
Via Benzinga
Why Amarin Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Biodexa Pharmaceuticals Plc (NASDAQ: BDRX) rose 43% to $6.91. 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Why Are Panbela Therapeutics Shares Trading Higher Today?
Panbela Therapeutics Inc (NASDAQ: PBLA) shares are trading higher after the company divested certain assets in its eflornithine pediatric neuroblastoma program to US WorldMeds 1 (USWM), a... 
Via Benzinga
Crude Oil Up 1%; M&T Bank Posts Upbeat Q2 Results
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 0.5% on Wednesday. The Dow traded up 0.53% to 35,137.16 while the NASDAQ rose 0.48% to 14,422.74. The S&P 500,... 
Via Benzinga
Dow Rises Over 100 Points; Goldman Sachs Earnings Miss Estimates
U.S. stocks traded higher this morning, with the Dow Jones gaining more than 100 points on Wednesday. Following the market opening Wednesday, the Dow traded up 0.37% to 35,082.94 while the NASDAQ rose... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Panbela Therapeutics to Receive a Total Up to $9.5 Million for Divestiture of Assets within Eflornithine (DFMO) Pediatric Neuroblastoma Program to US WorldMeds
From Panbela Therapeutics, Inc.
Via GlobeNewswire
Panbela Announces Issuance of New Patent in Australia Patent is for Claims of a Novel Process for the Production of SBP-101
Patent developed in collaboration with Syngene International Ltd. 
From Panbela Therapeutics, Inc.
Via GlobeNewswire
Panbela's Diverse Pipeline Is Encouraging Amidst Challenges In Pancreatic Cancer Therapy: Analyst
Panbela Therapeutics Inc (NASDAQ: PBLA) said that the independent Data Safety Monitoring Board (DSMB) of the Phase 3 ASPIRE trial for patients with untreated metastatic pancreatic ductal adenocarcinoma... 
Via Benzinga
Panbela Announces Preliminary Safety Analysis for ASPIRE Trial
From Panbela Therapeutics, Inc.
Via GlobeNewswire
Top 5 Health Care Stocks That Could Lead To Your Biggest Gains In July
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. 
Via Benzinga
BioMedNewsBreaks – Panbela Therapeutics Inc. (NASDAQ: PBLA) Closes on Public Offering Totaling About $8.5M
Via Investor Brand Network
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 SantaClara.com & California Media Partners, LLC. All rights reserved.